Join the free, hour-long , where authors will present their recently published ® (JVI) articles and share the story behind their research with the wider academic community. Presentations are followed by an open forum panel discussion with all speakers and participants. JVI editors will moderate the sessions, including the discussion and live Q&A.
The JVI Seminar Series is getting an upgrade. With Cassyni, you can do more than just watch a seminar—you can continue the conversation, quickly find the insights that matter most and stay connected to the latest virology research. Whether you join live or watch on demand, you'll be able to earn a certificate of attendance, ask questions anytime, search presentations and transcripts for key topics and discover related seminars, publications and discussions from the broader research community. It's a smarter, more interactive way to engage with groundbreaking research.
Virus, Vaccine, Village: Science and Society's Influences on the 2026 Bundibugyo Ebola Outbreak
Aug. 12, 2026 | 1 p.m. ET
Join us for the next JVI Seminar where Elizabeth Talbot, M.D. and Elizabeth Wrobel, Ph.D. will discuss the 2026 Bundibugyo ebolavirus outbreak in the Democratic Republic of Congo (DRC) and Uganda—its epidemiology, the accelerated push for vaccines, therapeutics and diagnostics, and the conflict-driven barriers shaping the response on the ground.
The 2026 Bundibugyo Ebola outbreak in the DRC and Uganda is unfolding without the medical toolkit that has helped contain past Ebola epidemics—no licensed vaccine, no approved treatment and only slow, infrastructure-heavy lab testing. At the same time, the response is playing out in one of the world's most fragile settings: an active conflict zone marked by deep community distrust, attacks on health workers and a health system already stretched before the outbreak began.
This webinar brings together the epidemiology of the outbreak, the accelerated push to develop vaccines, therapeutics and rapid diagnostics for an historically neglected virus species, and the cultural and structural forces shaping whether those tools can actually reach the people who need them. Participants will leave with a grounded, current understanding of both the science and the on-the-ground realities driving this response.
Key Learning Objectives:
- Describe the epidemiology of the 2026 Bundibugyo virus disease outbreak, including its transmission dynamics, geographic spread and how it compares to prior Ebola epidemics.
- Summarize the current status of vaccine, therapeutic and diagnostic development for Bundibugyo virus, including why existing Zaire-strain countermeasures don't reliably transfer and which candidates are furthest along.
- Identify the structural and cultural barriers, including armed conflict, community distrust and health workforce strain, that are shaping the effectiveness of the outbreak response.
- Explain how scientific and social factors interact and why closing the medical countermeasure gap alone will not be sufficient to control the outbreak without addressing trust and access.
Presenters
- Elizabeth Talbot, M.D., Geisel School of Medicine at Dartmouth, Hanover, N.H.
- Elizabeth Wrobel, Ph.D., Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Mont.
- Moderated and hosted by Felicia Goodrum, Ph.D., Geisel School of Medicine at Dartmouth, Hanover, N.H., co-Editor in Chief, Journal of Virology®
棉花糖直播 the Journal
The ® (JVI) is a 棉花糖直播 journal dedicated to publishing primary research, minireviews and other article formats that interrogate fundamental processes and structure in viruses, the mechanisms by which they interact and evolve with their host and environment, novel methodologies and therapeutic and diagnostic strategies.
Explore past Journal of Virology Seminar Series webinars on Cassyni.